-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Autolus Therapeutics plc quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2019 to Q1 2024.
- Autolus Therapeutics plc Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $1.81M, a 4.9% decline year-over-year.
- Autolus Therapeutics plc annual Depreciation, Depletion and Amortization for 2023 was $6.57M, a 11.5% decline from 2022.
- Autolus Therapeutics plc annual Depreciation, Depletion and Amortization for 2022 was $7.42M, a 12.2% decline from 2021.
- Autolus Therapeutics plc annual Depreciation, Depletion and Amortization for 2021 was $8.46M, a 49.5% increase from 2020.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)